Investors Snatch VRDN 28.9% Lower Than Its Secondary Stock Offering
April 18, 2024 at 11:22 AM EDT
Looking back to 92 days ago, Viridian Therapeutics Inc (VRDN) priced a 7,142,858 share secondary stock offering at $21.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..